These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11835067)

  • 1. The Pharmacokinetics and Pharmacodynamics of Methylprednisolone in Chronic Renal Failure.
    Milad MA; Ludwig EA; Lew KH; Kohli RK; Jusko WJ
    Am J Ther; 1994 Jun; 1(1):49-57. PubMed ID: 11835067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylprednisolone pharmacokinetics and pharmacodynamics in chronic renal failure.
    Jusko WJ; Milad MA; Ludwig EA; Lew KH; Kohli RK
    Clin Nephrol; 1995 Jan; 43 Suppl 1():S16-9. PubMed ID: 7781199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity.
    Dunn TE; Ludwig EA; Slaughter RL; Camara DS; Jusko WJ
    Clin Pharmacol Ther; 1991 May; 49(5):536-49. PubMed ID: 1827621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics.
    Slayter KL; Ludwig EA; Lew KH; Middleton E; Ferry JJ; Jusko WJ
    Clin Pharmacol Ther; 1996 Mar; 59(3):312-21. PubMed ID: 8653994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects.
    Kong AN; Ludwig EA; Slaughter RL; DiStefano PM; DeMasi J; Middleton E; Jusko WJ
    Clin Pharmacol Ther; 1989 Dec; 46(6):616-28. PubMed ID: 2689044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm.
    Fisher LE; Ludwig EA; Wald JA; Sloan RR; Middleton E; Jusko WJ
    Clin Pharmacol Ther; 1992 Jun; 51(6):677-88. PubMed ID: 1535301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of methylprednisolone sodium succinate and methylprednisolone in patients undergoing cardiopulmonary bypass.
    Kong AN; Jungbluth GL; Pasko MT; Beam TR; Jusko WJ
    Pharmacotherapy; 1990; 10(1):29-34. PubMed ID: 2179900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Food on the Pharmacokinetics and Pharmacodynamics of Torsemide.
    Kramer WG
    Am J Ther; 1995 Jul; 2(7):499-503. PubMed ID: 11850698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Pharmacokinetics of the Neuroprotective Agent NBQX.
    Ingwersen SH; Ohrström JK; Petersen P; Drustrup J; Bruno L; Nordholm L
    Am J Ther; 1994 Dec; 1(4):296-303. PubMed ID: 11835103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics.
    Lew KH; Ludwig EA; Milad MA; Donovan K; Middleton E; Ferry JJ; Jusko WJ
    Clin Pharmacol Ther; 1993 Oct; 54(4):402-14. PubMed ID: 8222483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of methylprednisolone hemisuccinate and methylprednisolone in chronic liver disease.
    Ludwig EA; Kong AN; Camara DS; Jusko WJ
    J Clin Pharmacol; 1993 Sep; 33(9):805-10. PubMed ID: 8227476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic interactions between diltiazem and methylprednisolone in healthy volunteers.
    Booker BM; Magee MH; Blum RA; Lates CD; Jusko WJ
    Clin Pharmacol Ther; 2002 Oct; 72(4):370-82. PubMed ID: 12386639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study of the pharmacokinetics of methylprednisolone after single and multiple intravenous doses of methylprednisolone sodium succinate and methylprednisolone suleptanate to healthy volunteers.
    Ferry JJ; Della-Coletta AA; Weber DJ; VanderLugt JT
    J Clin Pharmacol; 1994 Nov; 34(11):1109-15. PubMed ID: 7876403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling interactions between adrenal suppression and T-helper lymphocyte trafficking during multiple dosing of methylprednisolone.
    Chow FS; Sharma A; Jusko WJ
    J Pharmacokinet Biopharm; 1999 Dec; 27(6):559-75. PubMed ID: 11153446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic assessment of bioavailability for two prodrugs of methylprednisolone.
    Daley-Yates PT; Gregory AJ; Brooks CD
    Br J Clin Pharmacol; 1997 Jun; 43(6):593-601. PubMed ID: 9205819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid dose sparing: pharmacodynamic responses to single versus divided doses of methylprednisolone in man.
    Reiss WG; Slaughter RL; Ludwig EA; Middleton E; Jusko WJ
    J Allergy Clin Immunol; 1990 Jun; 85(6):1058-66. PubMed ID: 2191992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone suppression testing in chronic renal failure: pharmacokinetics of dexamethasone and demonstration of a normal hypothalamic-pituitary-adrenal axis.
    Workman RJ; Vaughn WK; Stone WJ
    J Clin Endocrinol Metab; 1986 Sep; 63(3):741-6. PubMed ID: 3734041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic effects of coadministration of methylprednisolone and tacrolimus in rabbits.
    Piekoszewski W; Chow FS; Jusko WJ
    J Pharmacol Exp Ther; 1994 Apr; 269(1):103-9. PubMed ID: 7513355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects.
    Lebrun-Vignes B; Archer VC; Diquet B; Levron JC; Chosidow O; Puech AJ; Warot D
    Br J Clin Pharmacol; 2001 May; 51(5):443-50. PubMed ID: 11422002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.